As "evidence-based research" on psychodynamic psychotherapy for children and adolescents gains momentum, it seems to be following adult psychiatry in moving increasingly toward biomedical/genetic efforts to understand and treat psychopathology. In this process, the clinical developmental model, which traces development and much psychopathology to the interaction between children's endowment and environment is being brushed aside in favor of genetic, biochemical and epidemiological efforts despite modest gains of clinical relevance to date from those approaches. As such, single case study continues to have an important place in identifying increasingly accurate clinical paradigms for understanding the development of psychopathology, which in turn leads toward developing more successful therapy. To this end, Treating the Other Third refers to that sizable minority of adolescent patients who fail to respond or refuse psychotropic medication. About the Author: H. Spencer Bloch has practiced child, adolescent, and adult psychiatry and psychoanalysis for forty-five years in San Rafael, CA. An honors graduate of Amherst and AOA from Cornell University Medical College, he completed medical internship at Bellevue Hospital in New York, and psychiatric residencies at Harvard's Massachusetts Mental Health Center, Judge Baker Guidance Center, and Children's Hospital Medical Center, serving as chief resident following military service in Vietnam and San Francisco. He trained and taught courses on adolescent and oedipal development at the San Francisco Psychoanalytic Institute, and is certified in child/adolescent, and adult psychoanalysis, and board certified in child/adolescent, and general psychiatry.
|